Zoryl MS 50mg/2mg/1000mg Tablet IR contains a combination of Sitagliptin 50mg, Glimepiride 2mg and Metformin 1000mg in immediate-release tablet form. It belongs to the ANTI DIABETIC category and is manufactured and marketed by Intas Pharmaceuticals Ltd.
Composition
- Sitagliptin: 50mg
- Glimepiride: 2mg
- Metformin: 1000mg
Product Information
- Product Name: Zoryl MS 50mg/2mg/1000mg Tablet IR
- Generic: Sitagliptin 50mg + Glimepiride 2mg + Metformin 1000mg
- Dosage Form: Immediate-Release Tablet
- Manufacturer: Intas Pharmaceuticals Ltd
- Marketer: Intas Pharmaceuticals Ltd
- Category: ANTI DIABETIC
About Sitagliptin, Glimepiride and Metformin
Sitagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by enhancing insulin release when blood glucose is elevated and reducing glucagon secretion.
Glimepiride is a sulfonylurea antidiabetic medicine that helps lower blood glucose by stimulating the pancreas to release insulin.
Metformin is an oral antidiabetic medicine that helps reduce blood glucose levels, primarily by decreasing glucose production in the liver and improving insulin sensitivity.
Usage Information
Use Zoryl MS 50mg/2mg/1000mg Tablet IR only as directed by your doctor or healthcare professional. Follow the prescribed dosage and schedule and do not change the dose without medical advice.
For complete product information, including dosage, storage instructions, precautions, contraindications, and expiry details, refer to the original packaging before use.
